Long-Acting Injectable Antipsychotic Use During Pregnancy: A Brief Review and Concise Guide for Clinicians

被引：17
|
作者：
Reinstein, Sarah A. [1 ]
Cosgrove, Jessica [1 ]
Malekshahi, Tara [1 ]
Deligiannidis, Kristina M. [1 ,2 ,3 ,4 ]
机构：
[1] Northwell Hlth, Zucker Hillside Hosp, Dept Psychiat, Glen Oaks, NY USA
[2] Zucker Sch Med Hofstra Northwell, Dept Psychiat, Hempstead, NY USA
[3] Zucker Sch Med Hofstra Northwell, Dept Obstet & Gynecol, Hempstead, NY USA
[4] Feinstein Inst Med Res, Manhasset, NY USA
来源：
JOURNAL OF CLINICAL PSYCHIATRY | 2020年 / 81卷 / 06期
关键词：
REAL-WORLD EFFECTIVENESS; 2ND-GENERATION ANTIPSYCHOTICS; NATIONWIDE COHORT; BIPOLAR DISORDER; SCHIZOPHRENIA; ASSOCIATION; PSYCHOSIS; SAFETY; WOMEN;
D O I：
10.4088/JCP.20ac13597
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia
    Kane, John M.
    McEvoy, Joseph P.
    Correll, Christoph U.
    Llorca, Pierre-Michel
    CNS DRUGS, 2021, 35 (11) : 1189 - 1205
  • [32] A Program to Increase the Appropriate Use of Long-Acting Injectable Antipsychotic Medications in Community Settings
    Velligan, Dawn, I
    Sajatovic, Martha
    Sierra, Cynthia
    Mintz, Jim
    Merker, Julie M.
    Cassidy, Kristin A.
    Runnels, Patrick
    PSYCHIATRIC SERVICES, 2021, 72 (09) : 1012 - 1017
  • [33] Long-Acting Injectable Antipsychotic Medications in Patients With Comorbid Schizophrenia and Substance Use Disorders
    Green, Alan I.
    JOURNAL OF DUAL DIAGNOSIS, 2012, 8 (01) : 62 - 63
  • [34] Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia
    John M. Kane
    Joseph P. McEvoy
    Christoph U. Correll
    Pierre-Michel Llorca
    CNS Drugs, 2021, 35 : 1189 - 1205
  • [35] Long-Acting Injectable Antipsychotic Use in Patients with Schizophrenia and Criminal Justice System Encounters
    Bhatta, Madhav P.
    Bista, Saroj
    El Khoury, Antoine C.
    Hutzell, Eric G.
    Tandon, Neeta
    Smith, Douglas
    JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCH, 2021, 8 (01): : 63 - 70
  • [36] DISTRIBUTION AND DETERMINANTS OF LONG-ACTING INJECTABLE ANTIPSYCHOTIC MEDICATION USE AMONG OLDER ADULTS
    Lohman, Matthew
    Verma, Mansi
    Jones, Paige
    Scott, Victoria
    Fields, Eve
    INNOVATION IN AGING, 2024, 8 : 161 - 161
  • [37] Long-Acting Injectable Antipsychotic Treatment in Schizophrenia and Co-occurring Substance Use Disorders: A Systematic Review
    Coles, Alexandria S.
    Knezevic, Dunja
    George, Tony P.
    Correll, Christoph U.
    Kane, John M.
    Castle, David
    FRONTIERS IN PSYCHIATRY, 2021, 12
  • [38] EVIDENCE FOR THE USE OF LONG-ACTING INJECTABLE ANTIPSYCHOTICS
    Amladi, Anjani
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2018, 57 (10): : S44 - S44
  • [39] The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
    Miyamoto S.
    Wolfgang Fleischhacker W.
    Current Treatment Options in Psychiatry, 2017, 4 (2) : 117 - 126
  • [40] A retrospective review of patterns of use of long-acting injectable buprenorphine products
    Daglish, Mark R. C.
    Hayllar, Jeremy S.
    McDonough, Mike
    DRUG AND ALCOHOL REVIEW, 2022, 41 : S51 - S51
12345